An industry consortium is tackling one of pharma’s biggest drug-related challenges.
Work by an international team in Japan has found a new and effective way to attack cancer inside the body.
Does CBD have the potential to reduce inflammation without hampering tissue regeneration?
A 2000-participant study in Europe has examined how drugs – and combinations of drugs – can affect the microbiota in our gut.
A drug development journey with origins in the 1950s has finally reached its successful conclusion: a new treatment for lupus
A Korean team have conducted a study on a peptide that could help to produce medicines capable of crossing cell membranes and interfering with PPIs
Mogrify's Karin Schmitt explains how epigenetic switches are support the conversion and maintenance of any clinically valuable cell types
Alzheimer’s research should benefit all, regardless of ethnicity or race
A new type of meta-DNA structure promises transformation in the fields of optoelectronics and synthetic biology
AstraZeneca's George Kirk tells us the story of Koselugo – a treatment for the rare genetic condition neurofibromatosis 1.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.
You will benefit from:
Express Insight into Bladder Cancer
Changing the Leopard’s Spots
Making It (Im)personal